Un-Audited Financial Results for the Quarter ended December 31, 2025, along with draft Limited Review Report pursuant to Regulation 33 of the Securities Exchange and Board of India (Listing ....
Awaiting price reaction for this filing.
Garodia Chemicals reported zero revenue from operations for Q3 FY26 and the nine months ended December 31, 2025, as the company has decided to cease its business. The company posted a small loss of ₹2.54 lakhs for the quarter, while showing a profit of ₹394.13 lakhs for the nine-month period — entirely due to a one-time ₹405.88 lakhs 'other income' from the settlement of loans owed by the promoters (Mr. Mahesh Garodia, Mr. Nishant Garodia, and M/s Garodia Sons Pvt Ltd) under a Base Resolution Plan approved by NCLT Mumbai. Total expenses were just ₹11.75 lakhs for 9M FY26, down from ₹8.51 lakhs a year earlier. EPS for 9M FY26 stood at ₹5.47 versus a loss of ₹0.12 per share in the comparable period.
This is a deeply negative signal for shareholders: the company has stopped its core operations, accounts are no longer being prepared on a going-concern basis, and the only profit came from a one-time NCLT-approved loan settlement. The auditor has flagged serious concerns including unconfirmed debtor/creditor balances and insufficient evidence on contingent liabilities, suggesting the stock carries significant risk and the underlying business has effectively wound down.